Announcement of the distribution record date for
cash dividend approved by the board
Date of events
2022/06/21
To which item it meets
paragraph 14
Statement
1.Date of the resolution by the board of directors or
shareholders' meeting, or of the decision by the company:2022/06/21
2.Type (ex-rights or ex-dividend) (please write "Ex-rights",
"Ex-dividend", or "Ex-rights and dividend"):Ex-dividend
3.Type and monetary amount of dividend distribution:
The total amount of cash dividends is NT$86,128,033
(NT$2.15 per share)
4.Ex-rights (Ex-dividend) date:2022/07/21
5.Last date before book closure:2022/07/22
6.Book closure starting date:2022/07/23
7.Book closure ending date:2022/07/27
8.Ex-rights (Ex-dividend) record date:2022/07/27
9.Deadline for applying the conversion of the debt voucher:NA
10.The closure period for the conversion of the debt voucher will
start from the date:NA
11.The closure period for the conversion of the debt voucher will
end on the date:NA
12.Payment date of cash dividend distribution:2022/08/19
13.Any other matters that need to be specified:
Syn-Tech will accept the transfer of the synthesis department that
spinning-off from SCP, the board has set July 1, 2022 as the
transaction date and the issuance of new shares. The proposed profit
distribution is affected by the above-mentioned event, it is proposed
that the chairman be authorized to adjust cash dividend payout ratio
based on the number of actual shares outstanding on the record date
for distribution.
Attachments
Original Link
Original Document
Permalink
Disclaimer
SYN-Tech Chem & Pharm Co. Ltd. published this content on 21 June 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 21 June 2022 08:53:02 UTC.
SYN-TECH Chem. & Pharm. Co., Ltd. is a Taiwan-based company principally engaged in the production, processing and distribution of active pharmaceutical ingredients (APIs). The Companyâs main products consist of muscle relaxants, local anesthetics, cardiovascular agents, antipyretics, analgesics and anti-inflammatory drugs, antimicrobials, spirit stabilizers, intermediates and others. It is also engaged in the pharmaceutical agency business. The Company distributes its products within Taiwan market and to overseas markets, including Asia, Europe, the Americas and Africa.